Please assess the completion status of the following clinical trial:

Trial Title: A Study Into the Effect of Seprafilm in Open Total Thyroidectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 21-75~* Histological confirmation of differentiated thyroid cancer requiring surgery, symptomatic goiters, thyroid nodules requiring histological analysis, or thyrotoxicosis poorly controlled by medication.~* Undergoing total thyroidectomy~Exclusion Criteria:~* Previous neck surgery~* Previous neck radiotherapy~* Patients with a known history of keloids~* Patients with a known history of motility disorders in the upper gastrointestinal tract and preexisting swallowing difficulty.~* Patients with metastatic disease; patients with disease that would require postop radiation therapy, radionuclide iodine therapy and any adjuvant therapies.~* Patients with advanced disease that would require radical or modified neck dissection~* Patients with lobe larger than 10 cm, or nodule larger than 8 cm which require extensive dissection that may confound the study~* Patients with connective tissue diseases and chronic diseases on long-term medications that may interfere with wound healings such as steroids

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Seprafilm (Sanofi, USA) (Type: ACTIVE_COMPARATOR): Patients in this arm received Seprafilm during surgery.
- Control (Type: NO_INTERVENTION): Patients in this arm does NOT receive Seprafilm during surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).